Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-21

Clinical Trial Update: Daily Liraglutide for Nicotine Dependence [Phase 2]

View source ↗

Summary

Phase 2 trial investigating daily liraglutide for nicotine dependence; completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Rebecca Ashare | Conditions: Smoking Cessation, Weight, Body | Phase 2 | Status: COMPLETED | Results posted: 2023-09-21